State of Michigan Retirement System boosted its stake in HCA Healthcare Inc (NYSE:HCA) by 10.8% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 67,282 shares of the company’s stock after buying an additional 6,562 shares during the quarter. State of Michigan Retirement System’s holdings in HCA Healthcare were worth $6,530,000 as of its most recent filing with the SEC.
A number of other large investors also recently made changes to their positions in the business. Cutler Group LP grew its holdings in shares of HCA Healthcare by 102.1% during the first quarter. Cutler Group LP now owns 300 shares of the company’s stock worth $26,000 after buying an additional 14,400 shares in the last quarter. City Holding Co. grew its stake in HCA Healthcare by 903.2% in the 1st quarter. City Holding Co. now owns 311 shares of the company’s stock worth $28,000 after acquiring an additional 280 shares during the period. Bessemer Group Inc. raised its holdings in HCA Healthcare by 57.8% in the 1st quarter. Bessemer Group Inc. now owns 363 shares of the company’s stock valued at $33,000 after acquiring an additional 133 shares during the last quarter. Solstein Capital LLC purchased a new position in shares of HCA Healthcare during the 1st quarter worth $36,000. Finally, Patriot Financial Group Insurance Agency LLC boosted its holdings in shares of HCA Healthcare by 60.8% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 534 shares of the company’s stock worth $48,000 after purchasing an additional 202 shares during the last quarter. Hedge funds and other institutional investors own 68.68% of the company’s stock.
A number of analysts have issued reports on the company. JPMorgan Chase & Co. raised their price target on HCA Healthcare from $142.00 to $161.00 and gave the stock an “overweight” rating in a research note on Friday, July 24th. Citigroup boosted their target price on shares of HCA Healthcare from $131.00 to $142.00 and gave the company a “buy” rating in a report on Thursday, July 23rd. SunTrust Banks increased their price target on shares of HCA Healthcare from $130.00 to $150.00 and gave the stock a “buy” rating in a research note on Thursday, July 23rd. Barclays lifted their price target on shares of HCA Healthcare from $117.00 to $127.00 and gave the company an “overweight” rating in a report on Wednesday, April 22nd. Finally, BMO Capital Markets downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $121.00 to $100.00 in a report on Monday, July 13th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $146.72.
In related news, insider Jon M. Foster sold 24,220 shares of the firm’s stock in a transaction on Wednesday, May 6th. The shares were sold at an average price of $100.19, for a total transaction of $2,426,601.80. Following the completion of the sale, the insider now directly owns 49,212 shares of the company’s stock, valued at approximately $4,930,550.28. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.80% of the stock is currently owned by corporate insiders.
HCA stock opened at $126.64 on Friday. The firm has a market cap of $42.76 billion, a P/E ratio of 13.06, a price-to-earnings-growth ratio of 1.09 and a beta of 1.30. The company has a debt-to-equity ratio of 54.19, a quick ratio of 0.95 and a current ratio of 1.09. HCA Healthcare Inc has a 1 year low of $58.38 and a 1 year high of $151.97. The stock has a 50-day simple moving average of $103.78 and a 200-day simple moving average of $114.34.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $3.23 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.94) by $4.17. The firm had revenue of $11.07 billion during the quarter, compared to analysts’ expectations of $10.44 billion. HCA Healthcare had a negative return on equity of 589.47% and a net margin of 6.67%. HCA Healthcare’s quarterly revenue was down 12.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.21 EPS. On average, equities research analysts predict that HCA Healthcare Inc will post 10.5 EPS for the current year.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.